Responses
Basic tumor immunology
Original research
Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
Compose a Response to This Article
Other responses
No responses have been published for this article.
